Wang JT, Smith J, Chen BC, Schmidt H, Rasoloson D, Paix A, et al
doi:10.1186/s12888-016-1049-5CrossRefGoogle ScholarPubMed Wang, L, Cai, Y, Fan, X
Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules
The collagen and GLP-1 connection that research reveals Here is where the science gets genuinely interesting
Unauthorised medicinal products are subject to UK medicines restrictions
This is where the conversation gets really interesting